Sanofi Board Nominates Christel Heydemann as Independent Director
Sanofi has nominated Christel Heydemann as an Independent Director, subject to shareholder approval at its AGM on 29 April. The company also announced that Patrick Kron, Independent Director and Chairman of the Nomination, Governance and CSR Committee, will step down at the end of his term.
Belén Garijo | 07/03/2026 | By News Bureau | 131
Kai Beckmann to Lead Merck as CEO and Executive Board Chair
The Board of Partners of E. Merck KG appointed Kai Beckmann as future Chairman of the Executive Board and CEO of Merck. Belén Garijo’s tenure to be completed as planned by end of April 2026.
Belén Garijo | 30/09/2025 | By Dineshwori | 202
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy